Cookies

Like most websites The Analytical Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Fields & Applications

Fields & Applications Mass Spectrometry

Spike Protein Potential

| Lauren Robertson

HDXMS reveals new therapeutic targets on SARS-Co-V2 spike protein

Fields & Applications COVID-19

Gelling with MS-Based Diagnosis

| Lauren Robertson

New gel electrophoresis method could enable rapid analysis of protein biomarkers in clinical specimens

Fields & Applications Genomics & DNA Analysis

The Vast Potential of Single-Cell Analysis

| Zachary Pitluk

Single-cell genomics is already powerful, but what are the next steps? And how do we get there?

Fields & Applications Food, Beverage & Agriculture

The Dark Metabolome in Your Glass

| Philippe Schmitt-Kopplin, Stefan Pieczonka

New knowledge of beer's dark metabolome provides a way to retrace the evolution of brewing – and civilization itself

Fields & Applications Food, Beverage & Agriculture

The (Analytical) Problem With “Cannabeverages”

Perkin Elmer's Toby Astill on why so-called cannabeverages present analytical challenges

Fields & Applications Clinical

Sniffing Out Prostate Cancer with Artificial Neural Networks

| Olivia Gaskill

Medical detection dogs are impractical for mass testing – so make way for a canine-mimicking, machine-based cancer detection system

Fields & Applications Chemical

The Return of CannaQAP

Melissa Phillips tells us about NIST’s mission to improve cannabis testing

Fields & Applications Spectroscopy

Venusian Views

| Lauren Robertson

Six-wavelength spectroscopy unveils new details about the surface of Venus

Fields & Applications Mass Spectrometry

The Call of Coronal Duty

| Lauren Robertson, Perdita Barran, Jeroen Demmers, Manfred Wuhrer

Jeroen Demmers, Perdita Barran and Manfred Wuhrer walk us through the proteomics battlegrounds in the fight against COVID-19

Fields & Applications Pharma & Biopharma

Getting Lipid Nanoparticle Production Right

| Sponsored by Knauer

KNAUER’s Matthias Luebbert discusses the company’s recent move into lipid nanoparticles

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register